Javascript must be enabled to continue!
Manuka Honey with Varying Levels of Active Manuka Factor (AMF) Ratings as an Anaerobic Fermentation Substrate for Limosilactobacillus reuteri DPC16
View through CrossRef
Manuka honey is known for its strong antibacterial effect against pathogens but can promote probiotic growth in certain conditions. In a two-factor ANOVA study, AMFTM Manuka honey (Active Manuka Factor: 05+, 10+, 15+ and 20+) was utilised as a substrate for probiotic Limosilactobacillus reuteri DPC16 in an anaerobic batch fermenter for 36 h. The biomass growth in MRS broth was noticeably higher with AMF Manuka honey than invert syrup and control samples without any additional sweetener source. The pH value was significantly lowered below 4.0 only in the AMF samples with the formation of lactic acid as the major metabolite. Other beneficial short-chain fatty acids (SCFA), such as acetic, succinic, and propionic acids, produced during the fermentation, along with the honey saccharides, were quantified by two-dimensional (2-D) nuclear magnetic resonance (NMR) spectroscopy. A significantly (p < 0.05) high biomass in AMF 20+ sample after 36 h, can partly be attributed to the high total sugar and oligosaccharide content in the honey. Importantly, however, no statistically significant difference was observed in the recorded major fermentation outcomes for the different AMF levels. The results, nevertheless, indicate the potential prebiotic efficacy of Manuka honey as a fermentation substrate for the lactobacilli probiotic strain.
Title: Manuka Honey with Varying Levels of Active Manuka Factor (AMF) Ratings as an Anaerobic Fermentation Substrate for Limosilactobacillus reuteri DPC16
Description:
Manuka honey is known for its strong antibacterial effect against pathogens but can promote probiotic growth in certain conditions.
In a two-factor ANOVA study, AMFTM Manuka honey (Active Manuka Factor: 05+, 10+, 15+ and 20+) was utilised as a substrate for probiotic Limosilactobacillus reuteri DPC16 in an anaerobic batch fermenter for 36 h.
The biomass growth in MRS broth was noticeably higher with AMF Manuka honey than invert syrup and control samples without any additional sweetener source.
The pH value was significantly lowered below 4.
0 only in the AMF samples with the formation of lactic acid as the major metabolite.
Other beneficial short-chain fatty acids (SCFA), such as acetic, succinic, and propionic acids, produced during the fermentation, along with the honey saccharides, were quantified by two-dimensional (2-D) nuclear magnetic resonance (NMR) spectroscopy.
A significantly (p < 0.
05) high biomass in AMF 20+ sample after 36 h, can partly be attributed to the high total sugar and oligosaccharide content in the honey.
Importantly, however, no statistically significant difference was observed in the recorded major fermentation outcomes for the different AMF levels.
The results, nevertheless, indicate the potential prebiotic efficacy of Manuka honey as a fermentation substrate for the lactobacilli probiotic strain.
Related Results
Enhanced Antibacterial Activity of MGOTM Manuka Honey complexed with a- cyclodextrin (Manuka Honey with CycloPowerTM)
Enhanced Antibacterial Activity of MGOTM Manuka Honey complexed with a- cyclodextrin (Manuka Honey with CycloPowerTM)
Background: Manuka honey is recognized for it’s health-promoting properties and it’s use in medicine is well documented. However, the actions of Manuka honey are limited by rapid d...
Comparison of Manuka Honey (Manuka Nd, G) and Etacridine Lactate (Rivanol) Applications in the Treatment of Infected Wounds in Cats
Comparison of Manuka Honey (Manuka Nd, G) and Etacridine Lactate (Rivanol) Applications in the Treatment of Infected Wounds in Cats
Background: Ethacridine lactate (Rivanol) has been used as an antibacterial drug in the treatment of infected wounds for many years. Although Manuka honey has been used in the trea...
Manuka honey with cycloPower™ ő a novel bioactive complex of manuka honey and α‐cyclodextrin (259.4)
Manuka honey with cycloPower™ ő a novel bioactive complex of manuka honey and α‐cyclodextrin (259.4)
Manuka honey is recognised for its health‐promoting properties and its use in medicine is well documented. However, the actions of Manuka honey are limited by rapid digestion and t...
Influence of Operating Conditions on Reuterin Production Using Resting Cells of Limosilactobacillus reuteri DPC16
Influence of Operating Conditions on Reuterin Production Using Resting Cells of Limosilactobacillus reuteri DPC16
Limosilactobacillus reuteri strains can secrete a potentially valuable chemical and broad-spectrum antimicrobial substance named reuterin (3-hydroxypropionaldehyde, 3-HPA). L. reut...
Determining the Contribution of Osmotic Stress to the Antibacterial Properties of Honey
Determining the Contribution of Osmotic Stress to the Antibacterial Properties of Honey
Researchers have repeatedly shown that honey possesses distinctive antimicrobial properties; however, there is uncertainty over which compounds in honey are responsible for these p...
Antibiofilm Activity of Manuka Honey in Combination with Antibiotics
Antibiofilm Activity of Manuka Honey in Combination with Antibiotics
We assessed the in vitro activity of Manuka honey against biofilm bacteria in combination with antibiotics and visualized the effect of Manuka honey on bacterial biofilms using sca...
Pemberdayaan Petani Lebah Madu Desa Kutosari melalui Diversifikasi Madu
Pemberdayaan Petani Lebah Madu Desa Kutosari melalui Diversifikasi Madu
One of the advantages of Kutosari Village is that it is a village that produces pure honey, because many of its people work as honey bee farmers. Honey bee farmers use existing for...
Both Manuka and Non-Manuka Honey Types Inhibit Antibiotic Resistant Wound-Infecting Bacteria
Both Manuka and Non-Manuka Honey Types Inhibit Antibiotic Resistant Wound-Infecting Bacteria
Postoperative infections are a major concern in United States hospitals, accounting for roughly 20% of all hospital-acquired infections yearly. Wound-infecting bacteria, in particu...

